GLSI
Price
$16.32
Change
-$2.69 (-14.15%)
Updated
Jul 17 closing price
Capitalization
239.55M
30 days until earnings call
Intraday BUY SELL Signals
SPRY
Price
$7.00
Change
-$0.46 (-6.17%)
Updated
Jul 17 closing price
Capitalization
694.63M
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLSI vs SPRY

GLSI vs SPRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLSI vs. SPRY commentary
Jul 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2026
Stock price -- (GLSI: $16.32 vs. SPRY: $7.00)
Brand notoriety: GLSI and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 124% vs. SPRY: 77%
Market capitalization -- GLSI: $239.55M vs. SPRY: $694.63M
GLSI [@Biotechnology] is valued at $239.55M. SPRY’s [@Biotechnology] market capitalization is $694.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $123.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, GLSI is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • GLSI’s TA Score: 4 bullish, 5 bearish.
  • SPRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -17.58% price change this week, while SPRY (@Biotechnology) price change was -11.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.96%. For the same industry, the average monthly price growth was +4.20%, and the average quarterly price growth was +1909.86%.

Reported Earning Dates

GLSI is expected to report earnings on Aug 17, 2026.

SPRY is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($695M) has a higher market cap than GLSI($240M). GLSI YTD gains are higher at: -22.323 vs. SPRY (-39.914). GLSI has higher annual earnings (EBITDA): -22.4M vs. SPRY (-90.79M). SPRY has more cash in the bank: 288M vs. GLSI (10.5M). SPRY has higher revenues than GLSI: SPRY (143M) vs GLSI (0).
GLSISPRYGLSI / SPRY
Capitalization240M695M35%
EBITDA-22.4M-90.79M25%
Gain YTD-22.323-39.91456%
P/E RatioN/A151.25-
Revenue0143M-
Total Cash10.5M288M4%
Total DebtN/A97.8M-
TECHNICAL ANALYSIS
Technical Analysis
GLSISPRY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 25 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOKFX36.44N/A
N/A
Fidelity OTC K6
ADCVX22.21N/A
N/A
American Century Disciplined Growth A
TCPWX13.15N/A
N/A
Transamerica Capital Growth R6
ESCKX18.98N/A
N/A
1290 Essex Small Cap Growth R
MEIHX53.82-0.19
-0.35%
MFS Value R3

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CELC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-14.15%
CELC - GLSI
37%
Loosely correlated
+0.10%
RZLT - GLSI
34%
Loosely correlated
+5.49%
MBIO - GLSI
32%
Poorly correlated
-2.53%
SPRY - GLSI
32%
Poorly correlated
-6.17%
ATYR - GLSI
31%
Poorly correlated
-1.18%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-6.17%
LPCN - SPRY
63%
Loosely correlated
-2.62%
LXEO - SPRY
33%
Poorly correlated
+2.85%
GLSI - SPRY
32%
Poorly correlated
-14.15%
TSHA - SPRY
31%
Poorly correlated
-0.17%
REPL - SPRY
31%
Poorly correlated
+7.46%
More